Cargando…

Expression of Stem Cell and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells of Breast Cancer Patients

Evaluation and characterization of circulating tumor cells (CTCs) have become a major focus of translational cancer research. Presence of CTCs predicts worse clinical outcome in early and metastatic breast cancer. Whether all cells from the primary tumor have potential to disseminate and form subseq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krawczyk, Natalia, Meier-Stiegen, Franziska, Banys, Malgorzata, Neubauer, Hans, Ruckhaeberle, Eugen, Fehm, Tanja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034492/ https://www.ncbi.nlm.nih.gov/pubmed/24895575 http://dx.doi.org/10.1155/2014/415721

Ejemplares similares

Clinical relevance of circulating tumor cells in ovarian, fallopian tube and peritoneal cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2020)

Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients
por: Krawczyk, Natalia, et al.
Publicado: (2019)

Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance
por: Reinhardt, Florian, et al.
Publicado: (2019)

Circulating and Disseminated Tumour Cells in Breast Carcinoma: Report from the Consensus Conference on Tumour Cell Dissemination during the 38th Annual Meeting of the German Society of Senology, Berlin, 14 June 2018
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2019)

Prognostic relevance of induced and spontaneous apoptosis of disseminated tumor cells in primary breast cancer patients
por: Krawczyk, Natalia, et al.
Publicado: (2014)

Potential Role of Circulating Tumor Cell Detection and Monitoring in Breast Cancer: A Review of Current Evidence
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2016)

Circulating tumour cells in breast cancer
por: Krawczyk, Natalia, et al.
Publicado: (2013)

Post-Neoadjuvant Treatment in HER2-Positive Breast Cancer: Escalation and De-Escalation Strategies
por: Krawczyk, Natalia, et al.
Publicado: (2022)

The Role and Clinical Relevance of Disseminated Tumor Cells in Breast Cancer
por: Banys, Malgorzata, et al.
Publicado: (2014)

Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical value
por: Franken, André, et al.
Publicado: (2023)

Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2012)

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
por: Aktas, Bahriye, et al.
Publicado: (2009)

Liquid Biopsy in Breast Cancer
por: Banys-Paluchowski, Maggie, et al.
Publicado: (2020)

Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers
por: Wu, Shiyang, et al.
Publicado: (2015)

Circulating and Disseminated Tumor Cells in Breast Carcinoma: Report from the Consensus Conference on Tumor Cell Dissemination during the 39th Annual Meeting of the German Society of Senology, Berlin, 27 June 2019
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2019)

The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells
por: Kölbl, Alexandra C., et al.
Publicado: (2016)

Circulating tumor cells with epithelial-mesenchymal transition markers as potential biomarkers for the diagnosis of lung cancer
por: Jiang, Sha-Sha, et al.
Publicado: (2021)

Co-Expression of Stem Cell and Epithelial Mesenchymal Transition Markers in Circulating Tumor Cells of Bladder Cancer Patients
por: Zhang, Ruiyun, et al.
Publicado: (2020)

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
por: Kallergi, Galatea, et al.
Publicado: (2011)

Epithelial–mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease
por: Li, Y-M, et al.
Publicado: (2013)

Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial
por: Banys, Malgorzata, et al.
Publicado: (2013)

Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program
por: Müller, V., et al.
Publicado: (2021)

Role of Epithelial-to-Mesenchymal Transition for the Generation of Circulating Tumors Cells and Cancer Cell Dissemination
por: Noubissi Nzeteu, Gaetan Aime, et al.
Publicado: (2022)

Epithelial Mesenchymal Transition: A New Insight into the Detection of Circulating Tumor Cells
por: Barrière, Guislaine, et al.
Publicado: (2012)

Cancer metastasis through the prism of epithelial‐to‐mesenchymal transition in circulating tumor cells
por: Micalizzi, Douglas S., et al.
Publicado: (2017)

Epithelial-mesenchymal transition of circulating tumor cells in prostate cancer is promoted by survivin
por: Yang, Faying, et al.
Publicado: (2020)

Circulating miRNAs Related to Epithelial–Mesenchymal Transitions (EMT) as the New Molecular Markers in Endometriosis
por: Zubrzycka, Anna, et al.
Publicado: (2021)

Detection of circulating tumor cells and evaluation of epithelial-mesenchymal transition patterns of circulating tumor cells in ovarian cancer
por: Jie, Xiao-Xiang, et al.
Publicado: (2022)

DanioCTC: Analysis of Circulating Tumor Cells from Metastatic Breast Cancer Patients in Zebrafish Xenografts
por: Reinhardt, Florian, et al.
Publicado: (2023)

Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma
por: Xu, Hua, et al.
Publicado: (2020)

Aspirin inhibit platelet-induced epithelial-to-mesenchymal transition of circulating tumor cells (Review)
por: LOU, XIAO-LIANG, et al.
Publicado: (2014)

Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer
por: Mego, M., et al.
Publicado: (2015)

Epithelial-to-mesenchymal transition, circulating tumor cells and cancer metastasis: Mechanisms and clinical applications
por: Jie, Xiao-Xiang, et al.
Publicado: (2017)

Epithelial-to-Mesenchymal Transition Gene Signature in Circulating Melanoma Cells: Biological and Clinical Relevance
por: Rapanotti, Maria Cristina, et al.
Publicado: (2023)

Molecular profiling of single circulating tumor cells with diagnostic intention
por: Polzer, Bernhard, et al.
Publicado: (2014)

Heterogeneity of expression of epithelial–mesenchymal transition markers in melanocytes and melanoma cell lines
por: Kim, Ji Eun, et al.
Publicado: (2013)

Evaluation of serum epidermal growth factor receptor (EGFR) in correlation to circulating tumor cells in patients with metastatic breast cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2017)

Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients
por: Huebner, Hanna, et al.
Publicado: (2018)

Epithelial-mesenchymal Transition and Cell Invasion
por: Son, Hwajin, et al.
Publicado: (2010)

Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice
por: Zhao, Xiao-Hui, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n4mn509767rlquk9k7omi0bord